iRhythm Technologies Inc at Canaccord Genuity Growth Conference Transcript
We've got standing room only, not surprising for this company. Again, my name is Jason Mills; I am the senior medical devices analyst at Canaccord. Welcome and thank you for attending our conference. Again, continuing a fairly vibrant discussion here, medtech morning, with one of the fastest-growing companies in medtech not only today but over the last two-plus years, almost three years since your IPO, right, Kevin?
Sure.
So, we're very happy to have iRhythm. Kevin King is the CEO. We also have Dan Wilson who's a new member of the management team. I know him from a previous life, but good to have you here, Dan.
And we can maybe try to take a few questions. Given the size of the audience there's obviously a lot of interest in iRhythm, but I am going to kick it off with Kevin. And I'd like to give you the opportunity to do what you probably do in a slide, at least to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
